Study to Compare the Awakening Threshold Effects of Belsomra 10 mg and 20 mg to Placebo in Non-elderly Insomniacs
Clinical trial NCT03312517 · COMPLETED
Trial details
- NCT number
- NCT03312517
- Sponsor
- Henry Ford Health System
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-04-15
- Primary completion
- 2018-10-25
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.